Intuitive solutions that improve resuscitation.





Sepsis affects over 1 million adults and children each year in the US. It is the most frequent cause of death in hospitalized patients and the leading killer of children worldwide. Early, rapid delivery of fluid is life-saving therapy, yet medical providers often face difficulty delivering fluids efficiently.
The challenges in obtaining intravenous (IV) access are compounded by the complexity of currently available fluid administration techniques.
A further barrier to IV infusion is resistance to rapid flow, which limits the effectiveness of resuscitation.



LifeFlow® is a hand-powered rapid infuser for critically ill patients who require urgent fluid delivery.

Easy to use and intuitive, LifeFlow is intended to allow front-line providers to deliver fluid quickly and efficiently and improve patient care.

Using the LifeFlow Rapid Infusion System, a trained user can, on average, deliver 1 liter of crystalloid fluid through a 20-gauge IV catheter in less than 5 minutes.



410 Medical’s mission is to improve caregivers’ ability to resuscitate patients. We take pride in offering innovative products and technologies for critical care. Our time and energy is focused on building strong relationships between our Company, our products, and the health care providers and hospitals we work closely with.
410 Medical takes its name from the calculation of an early fluid delivery goal in pediatric sepsis resuscitation:
4 x 10ml/kg boluses over 10 minutes = 410
The 40ml/kg threshold has been shown to improve survival in pediatric sepsis and is recommended by national guidelines, but is rarely achieved in clinical practice.



Kyle Chenet


Kyle has nearly 20 years of life sciences business and operations experience. Most recently he was founder and CEO of Lq3 Pharmaceuticals, a company dedicated to developing novel medicines to treat oral and head and neck diseases. Prior to launching Lq3, Kyle spent 6 years at Liquidia Technologies, where he helped build a life science business leveraging the PRINT® Technology Platform. Prior to Liquidia, Kyle had a variety of operational and business roles at GlaxoSmithKline, Abbott Laboratories and Biolex Therapeutics. Kyle holds a BS in Mechanical Engineering from the University of Michigan and an MBA from Stanford University.


Mark Piehl

CMO and Co-founder

Dr. Piehl is a pediatric intenstivist at WakeMed in Raleigh, NC, and served as Director of Pediatrics and Medical Director of the WakeMed Children’s Hospital from 2009-2015. His clinical interests include trauma, shock & sepsis, traumatic brain injury, airway management, critical care transport, ultrasound, and procedural sedation. Dr. Piehl has clinical faculty appointments in the Departments of Pediatrics at the University of North Carolina and Duke University, and teaches pediatric emergency and critical care skills to learners at all levels, with a particular interest in the use of medical simulation. Dr. Piehl received his BA from Davidson, as well as his MD and Master’s of Public Health from UNC Chapel Hill. He trained in pediatrics, internal medicine, and pediatric critical care at UNC. Dr. Piehl co-founded 410 Medical Innovation in 2013.


Galen Robertson

Chief Operating Officer

Galen Robertson is a mechanical engineer with extensive R&D experience in the medical device space. He has launched nine medical device product families, and is an inventor on over 30 US patents and 50 pending applications. Prior to joining 410 Medical Mr. Robertson served as Director of R&D at TransEnterix, where he completed initial development of a robotic surgical system. Previously he was at Johnson & Johnson in the Ethicon Endo-Surgery division, where he worked in R&D, in both design and manufacturing roles, on a variety of surgical devices, including Harmonic vessel sealers and surgical stapling devices. Mr. Robertson received BS and MS degrees in mechanical engineering from Georgia Tech and was a National Science Foundation Fellowship recipient.


Luke Roush


Luke Roush co-founded 410 Medical alongside Dr. Piehl in 2013. He is currently a Managing Principal of Sovereign’s Capital, the venture capital firm which he co-founded in 2012. Previously, Luke has twelve years of experience in global commercialization and business development at venture-backed and Fortune 500 companies. He was Vice President for Sales, Marketing, and Business Development at TransEnterix, a medical device company that developed and commercialized a minimally invasive surgical system in the US, Europe, and Middle East. Prior to joining TransEnterix, he served as Chief Operating Officer at Liquidia Technologies, a nanotechnology company focused on biopharmaceutical applications. Mr. Roush was also global marketing manager for Boston Scientific’s neurovascular stroke business. Mr. Roush graduated summa cum laude from Duke University, and earned his MBA from The Fuqua School of Business.


Bob Titkemeyer

Director of Quality & Regulatory

Mr. Titkemeyer has 25 years of experience in medical device startups, covering a diverse set of medical device products. With extensive knowledge of the domestic and international regulatory processes, Mr. Titkemeyer has successfully received authorization by FDA and CE mark regulatory authorities to market devices in 60 different countries, including China and Japan.


Please contact us with questions or ideas using the form below.

* Indicates required field.

For inquiries please contact:
(919) 241-7900


410 Medical Innovation
201 West Main St, Suite 207
Durham, NC 27701